Outpace Bio

About Outpace Bio

Outpace Bio is a company focused on revolutionizing cell therapy through AI-powered protein design. Their mission is to cure solid tumors by creating better biology, programming cells to make effective decisions inside patients, and developing cell therapies that are both effective and safe.

Products & Services

OUTSPACER™ Optimized CAR:A library of fully human sequences designed to maximize CAR T cell function for more potent killing of cancer cells, enhancing potency, specificity, and safety.

OUTSMART™ Designed Cytokine:Cytokines that stimulate immune cells in the tumor microenvironment to boost efficacy and safety of cell therapies by enabling a productive immune response.

OUTLAST™ T Cell Persistence:Technology that reprograms cell therapies to make better decisions inside patients, aiming for durable clinical responses by enhancing persistence.

OUTSAFE™ Safety Switch:A fully human safety switch (EGFRopt™) that responds to cetuximab, used for maximizing potency, specificity, safety, and for cell selection during manufacturing.

CO-LOCKR™ Logic Gated Targeting:Technology enabling cell therapies to recognize unique protein fingerprints on cancer cells, allowing safe treatment of various cancer types with high specificity.

Specialties

AI-Powered Protein Design Cell Therapy Cancer Treatment Computational & Structural Biology Synthetic Biology Translational Immunology Cell Programming

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B T: - FT: Series B	A: 144000000 MR: - FA: $144 million FAN: 144000000	D: 2024-08-01 FD: 2024-08-01	15 investors

Series B Latest

2024-08-01

$144.0M

15 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

D

David Baker

Director of the Institute for Protein Design and Professor of Biochemistry

M

Marc Lajoie

Co-founder & Chief Executive Officer

S

Scott Boyken

Co-founder & Chief Technology Officer

S

Stanley Riddell

Co-Founder and Scientific Advisor

R

Rick Klausner

Co-founder

C

Crystal Mackall

View 22 more team members with Pro

Unlock Full Team Directory

Recent News

Outpace Bio Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised